Compare PCRX & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | IMXI |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 456.2M |
| IPO Year | 2011 | N/A |
| Metric | PCRX | IMXI |
|---|---|---|
| Price | $26.32 | $15.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $32.86 | $16.67 |
| AVG Volume (30 Days) | ★ 821.1K | 228.2K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 1.29 |
| Revenue | ★ $716,791,000.00 | $625,123,000.00 |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $9.53 | $0.95 |
| P/E Ratio | $54.91 | ★ $11.92 |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $18.17 | $8.58 |
| 52 Week High | $27.64 | $22.30 |
| Indicator | PCRX | IMXI |
|---|---|---|
| Relative Strength Index (RSI) | 64.48 | 60.67 |
| Support Level | $25.48 | $15.35 |
| Resistance Level | $27.16 | $15.51 |
| Average True Range (ATR) | 1.00 | 0.06 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 77.18 | 39.62 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.